Dealmaking: Q3 Roundup Shows Deal Values Jump From Prior Quarter
A look at M&A and alliance activity across the medical device and in vitro diagnostics industries, July-September 2020
Device company M&A values reached $17.9bn in Q3, while in vitro diagnostic firms and research tools players completed M&A activity that totaled $8.2bn.
You may also be interested in...
The year's biggest M&A deal, along with billion dollar alliances marked out December's dealmaking credentials.
Five $1bn+ alliances were penned in November. Topping the list was a potential $4.5bn deal between Arcturus Therapeutics and CSL Seqirus.
Two $1bn+ alliances were penned in October. Financing reached $7.7bn in biopharma, $636m in device, and $140m in diagnostics.